Silica Nanoparticles in Head and Neck Cancer
Author Information
Author(s): Besic Gyenge Emina, Darphin Xenia, Wirth Amina, Pieles Uwe, Walt Heinrich, Bredell Marius, Maake Caroline
Primary Institution: Institute of Anatomy, University of Zürich
Hypothesis
Can surface modified silica nanoparticles improve drug delivery and imaging in head and neck squamous cell carcinoma?
Conclusion
Silica-based nanoparticles may serve as useful tools for developing novel treatment options in head and neck squamous cell carcinoma due to their long intracellular persistence.
Supporting Evidence
- Silica nanoparticles were found to be internalized by cancer cells within 30 minutes.
- The uptake of Ru@SiO2-PEG nanoparticles was minimal compared to other types.
- Nanoparticles persisted in cells over five passages without causing significant changes in cell morphology.
Takeaway
This study looked at tiny particles made of silica to see if they could help treat a type of throat cancer. They found that these particles can stay inside the cancer cells for a long time without hurting them.
Methodology
The study analyzed the cytotoxicity, uptake, and intracellular fate of silica nanoparticles in the human HNSCC cell line UMB-SCC 745 using various microscopy techniques.
Limitations
The study primarily focused on in-vitro conditions, which may not fully represent in-vivo behavior.
Participant Demographics
The cell line used was derived from a 48-year-old male with a tonsil tumor.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website